Hepatic stellate cells in inflammation-fibrosis-carcinoma axis

Anatomical Record

Volumn 293, Issue 9, 2010, Pages 1492-1496

  Wang, Bin Bin ^a   Cheng, Jun Yao ^a   Gao, Hong Hao ^a   Zhang, Yang ^a   Chen, Zhi Nan ^a   Bian, Huijie ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cirrhosis; Hepatic stellate cell; Hepatocellular carcinoma; Liver fibrosis; Liver inflammation; Myofibroblast

Indexed keywords

CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CARCINOMA; CELL ACTIVATION; CELL FUNCTION; CHRONIC HEPATITIS; DISEASE ASSOCIATION; HEPATITIS; HUMAN; INFLAMMATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; STELLATE CELL; CYTOLOGY; LIVER; LIVER TUMOR; PATHOLOGY; SIGNAL TRANSDUCTION;

CARCINOMA, HEPATOCELLULAR; HEPATIC STELLATE CELLS; HUMANS; INFLAMMATION; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 77956596745     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.21173     Document Type: Review

References (46)

1. Amann T, Bataille F, Spruss T, Mühlbauer M, Gäbele E, Schölmerich J, Kiefer P, Bosserhoff AK, Hellerbrand C. 2009. Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Cancer Sci 100:646-653.
2. Bataller R, Brenner DA. 2005. Liver fibrosis. J Clin Invest 115:209-218.
3. Borkham-Kamphorst E, van Roeyen CR, Ostendorf T, Floege J, Gressner AM, Weiskirchen R. 2007. Pro-fibrogenic potential of PDGF-D in liver fibrosis. J Hepatol 46:1064-1074. (Pubitemid 46669736)
4. Bourd-Boittin K, Basset L, Bonnier D, L'helgoualc'h A, Samson M, Théret N. 2009. CX3CL1/fractalkine shedding by human hepatic stellate cells: contribution to chronic inflammation in the liver. J Cell Mol Med 13:1526-1535.
5. Bruno R, Galastri S, Sacchi P, Cima S, Caligiuri A, Defranco R, Milani S, Gessani S, Fantuzzi L, Liotta F, Frosali F, Antonucci G, Pinzani M, Marra F. 2010. The HIV Envelope Protein GP120 Modulates The Biology of Human Hepatic Stellate Cells: A Link Between HIV Infection and Liver Fibrogenesis. Gut 59:513-520.
6. Campbell JS, Hughes SD, Gilbertson DG, Palmer TE, Holdren MS, Haran AC, Odell MM, Bauer RL, Ren HP, Haugen HS, Yeh MM, Fausto N. 2005. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci USA 102:3389-3394. (Pubitemid 40328055)
7. Connolly MK, Bedrosian AS, Mallen-St Clair J, Mitchell AP, Ibrahim J, Stroud A, Pachter HL, Bar-Sagi D, Frey AB, Miller G. 2009. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. J Clin Invest 119:3213-3225.
8. Czochra P, Klopcic B, Meyer E, Herkel J, Garcia-Lazaro JF, Thieringer F, Schirmacher P, Biesterfeld S, Galle PR, Lohse AW, Kanzler S. 2006. Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice. J Hepatol 45:419-428. (Pubitemid 44142114)
9. De Minicis S, Brenner DA. 2007. NOX in liver fibrosis. Arch Biochem Biophys 462:266-272.
10. Dooley S, Delvoux B, Streckert M, Bonzel L, Stopa M, ten Dijke P, Gressner AM. 2001. Transforming growth factor β signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts: TGFβ signal transduction during transdifferentiation of hepatic stellate cells. FEBS Lett 502:4-10.
11. Dooley S, Hamzavi J, Breitkopf K, Wiercinska E, Said HM, Lorenzen J, Ten Dijke P, Gressner AM. 2003. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 125:178-191. (Pubitemid 36799118)
12. Elsharkawy AM, Mann DA. 2007. Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis. Hepatology 46:590-597.
13. Faouzi S, Lepreux S, Bedin C, Dubuisson L, Balabaud C, Bioulac-Sage P, Desmoulière A, Rosenbaum J. 1999. Activation of cultured rat hepatic stellate cells by tumoral hepatocytes. Lab Invest 79:485-493. (Pubitemid 29190438)
14. Friedman SL. 2008a. Mechanisms of hepatic fibrogenesis. Gastroenterology 134:1655-1669.
15. Friedman SL. 2008b. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88:125-172.
16. Guo CJ, Pan Q, Li DG, Sun H, Liu BW. 2009. miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis. J Hepatol 50:766-778.
17. Haybaeck J, Zeller N, Wolf MJ, Weber A, Wagner U, Kurrer MO, Bremer J, Iezzi G, Graf R, Clavien PA, Thimme R, Blum H, Nedospasov SA, Zatloukal K, Ramzan M, Ciesek S, Pietschmann T, Marche PN, Karin M, Kopf M, Browning JL, Aguzzi A, Heikenwalder M. 2009. A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell 16:295-308.
18. Henderson NC, Forbes SJ. 2008. Hepatic fibrogenesis: from within and outwith. Toxicology 254:130-135.
19. Johnson SJ, Burr AW, Toole K, Dack CL, Mathew J, Burt AD. 1998. Macrophage and hepatic stellate cell responses during experimental hepatocarcinogenesis. J Gastroenterol Hepatol 13:145-151. (Pubitemid 28137913)
20. Ju MJ, Qiu SJ, Fan J, Xiao YS, Gao Q, Zhou J, Li YW, Tang ZY. 2009. Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection. Am J Clin Pathol 131:498-510.
21. Kisseleva T, Brenner DA. 2007. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J Gastroenterol Hepatol 22 (Suppl 1):S73-S78.
22. Knittel T, Dinter C, Kobold D, Neubauer K, Mehde M, Eichhorst S, Ramadori G. 1999. Expression and regulation of cell adhesion molecules by hepatic stellate cells (HSC) of rat liver: involvement of HSC in recruitment of inflammatory cells during hepatic tissue repair. Am J Pathol 154:153-167.
23. Lang A, Sakhnini E, Fidder HH, Maor Y, Bar-Meir S, Chowers Y. 2005. Somatostatin inhibits proinflammatory cytokine secretion from rat hepatic stellate cells. Liver Int 25:808-816.
24. Li YL, Wu J, Wei D, Zhang DW, Feng H, Chen ZN, Bian H. 2009. Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice. Liver Int 29:593-602.
25. Liu X, Hu H, Yin JQ. 2006. Therapeutic strategies against TGFbeta signaling pathway in hepatic fibrosis. Liver Int 26:8-22.
26. Liu Y, Wen XM, Lui EL, Friedman SL, Cui W, Ho NP, Li L, Ye T, Fan ST, Zhang H. 2009. Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787/ ZK22258. Lab Invest 89:1152-1160.
27. Mann J, Mann DA. 2009. Transcriptional regulation of hepatic stellate cells. Adv Drug Deliv Rev 61:497-512.
28. Mann J, Chu DC, Maxwell A, Oakley F, Zhu NL, Tsukamoto H, Mann DA. 2010. MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology 138:705-714.
29. Martín-Vílchez S, Sanz-Cameno P, Rodríguez- Muñoz Y, Majano PL, Molina-Jiménez F, López-Cabrera M, Moreno-Otero R, Lara-Pezzi E. 2008. The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells. Hepatology 47:1872-1883.
30. Mikula M, Proell V, Fischer AN, Mikulits W. 2006. Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF-beta dependent fashion. J Cell Physiol 209:560-567.
31. Musso O, Théret N, Campion JP, Turlin B, Milani S, Grappone C, Clément B. 1997. In situ detection of matrix metalloproteinase-2 (MMP2) and the metalloproteinase inhibitor TIMP2 transcripts in human primary hepatocellular carcinoma and in liver metastasis. J Hepatol 26:593-605.
32. Nhieu JT, Brochériou I, Préaux AM, Mallat A, Cherqui D, Zafrani ES, Mavier P. 1998. Myofibroblasts and hepatocellular carcinoma: an in vivo and in vitro study. J Hepatol 29:120-128.
33. Novo E, di Bonzo LV, Cannito S, Colombatto S, Parola M. 2009. Hepatic myofibroblasts: a heterogeneous population of multifunctional cells in liver fibrogenesis. Int J Biochem Cell Biol 41:2089-2093.
34. Ooi LP, Crawford DH, Gotley DC, Clouston AD, Strong RW, Gobe GC, Halliday JW, Bridle KR, Ramm GA. 1997. Evidence that "myofibroblast-like" cells are the cellular source of capsular collagen in hepatocellular carcinoma. J Hepatol 26:798-807.
35. Pinzani M. 2002. PDGF and signal transduction in hepatic stellate cells. Front Biosci 7:d1720-d1726.
36. Schnabl B, Kweon YO, Frederick JP, Wang XF, Rippe RA, Brenner DA. 2001. The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology 34:89-100.
37. Schulze-Krebs A, Preimel D, Popov Y, Bartenschlager R, Lohmann V, Pinzani M, Schuppan D. 2005. Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells. Gastroenterology 129:246-258.
38. Son G, Hines IN, Lindquist J, Schrum LW, Rippe RA. 2009. Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis. Hepatology 50:1512-1523.
39. Taura K, De Minicis S, Seki E, Hatano E, Iwaisako K, Osterreicher CH, Kodama Y, Miura K, Ikai I, Uemoto S, Brenner DA. 2008. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis. Gastroenterology 135:1729-1738.
40. Taura K, Miura K, Iwaisako K, Osterreicher CH, Kodama Y, Penz- Österreicher M, Brenner DA. 2010. Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology 51:1027-1036.
41. Théret N, Musso O, Turlin B, Lotrian D, Bioulac-Sage P, Campion JP, Boudjéma K, Clément B. 2001. Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas. Hepatology 34:82-88.
42. Torimura T, Sata M, Ueno T, Kin M, Tsuji R, Suzaku K, Hashimoto O, Sugawara H, Tanikawa K. 1998. Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma. Hum Pathol 29:986-991.
43. Venugopal SK, Jiang J, Kim TH, Li Y, Wang SS, Torok NJ, Wu J, Zern MA. 2009. Liver fibrosis causes down-regulation of miRNA-150 and miRNA-194 in hepatic stellate cells and their overexpression causes decreased stellate cell activation. Am J Physiol Gastrointest Liver Physiol, in press.
44. Verslype C, Van Cutsem E, Dicato M, Arber N, Berlin JD, Cunningham D, De Gramont A, Diaz-Rubio E, Ducreux M, Gruenberger T, Haller D, Haustermans K, Hoff P, Kerr D, Labianca R, Moore M, Nordlinger B, Ohtsu A, Rougier P, Scheithauer W, Schmoll HJ, Sobrero A, Tabernero J, van de Velde C. 2009. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008. Ann Oncol 20 (Suppl 7):vii1-vii6.
45. Wirz W, Antoine M, Tag CG, Gressner AM, Korff T, Hellerbrand C, Kiefer P. 2008. Hepatic stellate cells display a functional vascular smooth muscle cell phenotype in a three-dimensional co-culture model with endothelial cells. Differentiation 76:784-794.
46. Wong CM, Ng IO. 2008. Molecular pathogenesis of hepatocellular carcinoma. Liver Int 28:160-174.